Cargando…

Impact of social and mobility restrictions in Parkinson’s disease during COVID-19 lockdown

BACKGROUND: The consequences of strict COVID-19 mobility restrictions on motor/non-motor features in Parkinson’s disease (PD) have not been systematically studied but worse mobility and quality of life have been reported. To elucidate this question, 12 mild to moderate PD patients were assessed in M...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luis-Martínez, Raquel, Di Marco, Roberto, Weis, Luca, Cianci, Valeria, Pistonesi, Francesca, Baba, Alfonc, Carecchio, Miryam, Biundo, Roberta, Tedesco, Chiara, Masiero, Stefano, Antonini, Angelo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404403/ https://www.ncbi.nlm.nih.gov/pubmed/34461838 http://dx.doi.org/10.1186/s12883-021-02364-9

Ejemplares similares

Effect of Intensive Rehabilitation Program in Thermal Water on a Group of People with Parkinson’s Disease: A Retrospective Longitudinal Study
por: Di Marco, Roberto, et al.
Publicado: (2022)

Clinical, cognitive, and morphometric profiles of progressive supranuclear palsy phenotypes
por: Campagnolo, Marta, et al.
Publicado: (2023)

Impact of Cognitive Profile on Impulse Control Disorders Presence and Severity in Parkinson's Disease
por: Martini, Alice, et al.
Publicado: (2019)

Cognitive decline in Parkinson’s disease: the complex picture
por: Biundo, Roberta, et al.
Publicado: (2016)

Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Correction to: Long-term safety, discontinuation and mortality in an Italian cohort with advanced Parkinson’s disease on levodopa/carbidopa intestinal gel infusion
por: Garrì, Federica, et al.
Publicado: (2022)

Quantification of Brain β-Amyloid Load in Parkinson's Disease With Mild Cognitive Impairment: A PET/MRI Study
por: Garon, Michela, et al.
Publicado: (2022)

Asymmetric Dopamine Transporter Loss Affects Cognitive and Motor Progression in Parkinson's Disease
por: Fiorenzato, Eleonora, et al.
Publicado: (2021)

The contribution of beta-amyloid to dementia in Lewy body diseases: a 1-year follow-up study
por: Biundo, Roberta, et al.
Publicado: (2021)

Grey Matter Changes in Cognitively Impaired Parkinson's Disease Patients
por: Rektorova, Irena, et al.
Publicado: (2014)

Anatomical Correlates of Cognitive Functions in Early Parkinson's Disease Patients
por: Biundo, Roberta, et al.
Publicado: (2013)

Personalized Care in Late-Stage Parkinson’s Disease: Challenges and Opportunities
por: Fabbri, Margherita, et al.
Publicado: (2022)

Parkinson disease in Gaucher disease
por: Rodriguez-Porcel, Federico, et al.
Publicado: (2017)

Antiphospholipid‐Related Chorea: Two Case Reports and Role of Metabolic Imaging
por: Lerjefors, Lisa, et al.
Publicado: (2022)

Predicting Cognitive Decline in Parkinson’s Disease: Can We Ask the Genes?
por: De Marchi, Fabiola, et al.
Publicado: (2014)

Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy
por: Vallelunga, Annamaria, et al.
Publicado: (2014)

Reduced Effective Connectivity in the Motor Cortex in Parkinson’s Disease
por: Formaggio, Emanuela, et al.
Publicado: (2021)

Neurotransmitter and receptor systems in the subthalamic nucleus
por: Emmi, Aron, et al.
Publicado: (2023)

The ‘welcomed lockdown’ hypothesis? Mental wellbeing and mobility restrictions
por: Costa-Font, Joan, et al.
Publicado: (2022)

Emerging Monogenic Complex Hyperkinetic Disorders
por: Carecchio, Miryam, et al.
Publicado: (2017)

The clinical and genetic spectrum of primary familial brain calcification
por: Carecchio, Miryam, et al.
Publicado: (2023)

Proprioceptive Based Training for stroke recovery. Proposal of new treatment modality for rehabilitation of upper limb in neurological diseases
por: Kiper, Pawel, et al.
Publicado: (2015)

Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy‐Parkinsonism From Parkinson's Disease
por: Quattrone, Andrea, et al.
Publicado: (2022)

Apomorphine and Levodopa Infusion Therapies for Advanced Parkinson’s Disease
por: Antonini, Angelo
Publicado: (2009)

High prolactin levels in dihydropteridine reductase deficiency: A sign of therapy failure or additional pathology?
por: Vitturi, Nicola, et al.
Publicado: (2021)

Acceptability to patients, carers and clinicians of an mHealth platform for the management of Parkinson’s disease (PD_Manager): study protocol for a pilot randomised controlled trial
por: Antonini, Angelo, et al.
Publicado: (2018)

Adaptation and destabilization of interpersonal relationships in sport and music during the Covid-19 lockdown
por: Antonini Philippe, Roberta, et al.
Publicado: (2020)

Action Selection and Motor Decision Making: Insights from Transcranial Magnetic Stimulation
por: Tecilla, Margherita, et al.
Publicado: (2022)

Toward objective monitoring of Parkinson's disease motor symptoms using a wearable device: wearability and performance evaluation of PDMonitor(®)
por: Antonini, Angelo, et al.
Publicado: (2023)

The Neural Correlates of Spatial and Object Working Memory in Elderly and Parkinson's Disease Subjects
por: Caminiti, Silvia P., et al.
Publicado: (2015)

Dopaminergic Medication Modulates Learning from Feedback and Error-Related Negativity in Parkinson’s Disease: A Pilot Study
por: Volpato, Chiara, et al.
Publicado: (2016)

The Length of SNCA Rep1 Microsatellite May Influence Cognitive Evolution in Parkinson’s Disease
por: Corrado, Lucia, et al.
Publicado: (2018)

Editorial: Impulse Control Disorders, Impulsivity and Related Behaviors in Parkinson's Disease
por: Rodríguez-Violante, Mayela, et al.
Publicado: (2019)

Once-daily pramipexole for the treatment of early and advanced idiopathic Parkinson’s disease: implications for patients
por: Antonini, Angelo, et al.
Publicado: (2011)

Current and novel infusion therapies for patients with Parkinson's disease
por: Antonini, Angelo, et al.
Publicado: (2023)

Biology of Muscle Atrophy and of its Recovery by FES in Aging and Mobility Impairments: Roots and By-Products
por: Carraro, Ugo, et al.
Publicado: (2015)

Does the Score on the MRC Strength Scale Reflect Instrumented Measures of Maximal Torque and Muscle Activity in Post-Stroke Survivors?
por: Kiper, Pawel, et al.
Publicado: (2021)

Prevalence of Extrapyramidal Symptoms in In-Patients With Severe Mental Illnesses: Focus on Parkinsonism
por: Roiter, Beatrice, et al.
Publicado: (2020)

Technology-Enabled Care: Integrating Multidisciplinary Care in Parkinson's Disease Through Digital Technology
por: Luis-Martínez, Raquel, et al.
Publicado: (2020)

What is Functional Mobility Applied to Parkinson’s Disease?
por: Bouça-Machado, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_icgj5g6camla2f1r48nmior4eg